Sean Bennett

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age

William L. Heyward, Michael Kyle, Joseph Blumenau et al. · Vaccine · 2013 · 120 citations

Vaccination, Vaccine Safety, Vaccinology +13

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial

Hennie Geldenhuys, Helen Mearns, David J. C. Miles et al. · Vaccine · 2015 · 79 citations

Vaccination, Immunology, Vaccine Trial +8

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

Robert S. Janssen, Roberto Mangoo‐Karim, Pablo E. Pérgola et al. · Vaccine · 2013 · 78 citations

Vaccination, Toll-like Receptor 9, Agonist Adjuvant +12

DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression

Rebecca Resnick, Chao-Jen Wong, Danielle C. Hamm et al. · Cell Reports · 2019 · 54 citations · Full text

CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells

Andrew P. Fontenot, Laia Gharavi, Sean Bennett et al. · Journal of Clinical Investigation · 2003 · 51 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Target Organ Versus +18